HEALTH● LOWJul 24 · Jul 24, 2026, 12:58 PM
Merck signs licensing deals with companies including Viatris for new HIV pill
Seeking Alpha Tech
Merck has entered into licensing agreements with multiple companies, including Viatris, concerning a new HIV medication.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH31m agoOne in three young adults use AI chatbots for drug and alcohol information, study findsEuroNews [en]HEALTH1h agoEBOLA: The Bundibugyo Strain Does Not Show Symptoms Early In Patients, Virologist WarnsChannels TVHEALTH1h agoEbola: FG confirms evacuation of Nigeria’s index patient, husband to SwitzerlandVanguard NigeriaHEALTHBREAKING1h agoEbola: Suspected index patient evacuated from Nigeria by air ambulance – ReportVanguard Nigeria